版权说明 操作指南
首页 > 成果 > 详情

PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports.

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Chen, Shanshan;Ouyang, Linqi;Li, Lian;Xiao, Yuyang;Wang, Shengfeng
作者机构:
[Chen, Shanshan; Wang, Shengfeng] Department of Pharmacy, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
[Ouyang, Linqi] Department of Pharmacy, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
[Li, Lian] Department of Information, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
[Xiao, Yuyang] Xiangya School of Medicine, Central South University, Changsha, Hunan, China
[Wang, Shengfeng] Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China
语种:
英文
关键词:
PD-1/PD-L1 inhibitors;characteristic;disproportionality analysis;hypophysitis;managements
期刊:
Drug Discoveries & Therapeutics
ISSN:
1881-7831
年:
2024
卷:
18
期:
1
页码:
34-43
机构署名:
本校为其他机构
院系归属:
药学院
摘要:
To get a thorough understanding of PD-1/L1 inhibitor-related hypophysitis (PD-1/L1-irH), we utilized a combination of disproportionality analysis and case analysis to comprehensively characterize the clinical features of PD-1/L1-irH. Significant signals of hypophysitis were detected for all PD-1/PD-L1 inhibitors in the FAERS (FDA Adverse Event Reporting System). As revealed by both FAERS and the case analysis, PD-1/L1-irH occurred more commonly in males, PD-1 inhibitors users and patients older than 65 years. The median onset time was 101 days in FAERS and 8 cycles in the case analysis. In the...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com